Colin advises clients throughout their lifecycle (all the way from start-up/spin-out to multinational listed companies) on the commercialisation of their intellectual property rights. In particular, advising on licensing deals, collaborations and R&D projects, distribution and manufacturing and the IP, commercial and regulatory aspects of M&A, VC investments and IPOs.

Having a 1st class degree in Cell Biology his practice has naturally become focused on the life sciences, healthcare and technology (with a particular focus on med-tech and clean-tech) sectors.

CV ansehen CV ausblenden

Aktuelle News & Insights

pipette
Synapse

Private equity investment in life sciences sector

30. Juli 2020
IN-DEPTH ANALYSIS

von mehreren Autoren

Klicken Sie hier für Details
scientist-with-molecule-models
Life Sciences & Healthcare

Licensing out: Try not to get benched

27. Juli 2020
IN-DEPTH ANALYSIS

von Colin McCall und Justyna Ostrowska

Klicken Sie hier für Details
pipette
Synapse

Arbitration for life sciences companies

29. Juni 2020
IN-DEPTH ANALYSIS

von mehreren Autoren

Klicken Sie hier für Details
centrifuge-machine
Synapse

Territorial licensing: "start at the end before you begin"

25. Juni 2020
IN-DEPTH ANALYSIS

von Colin McCall und Justyna Ostrowska

Klicken Sie hier für Details

Meet me at

Alle Veranstaltungen und Webinare finden Sie auf unserer Event-Seite.